Therapeutic effects of Ulinastatin on experimental crescentic glomerulonephritis in rats

Nephron

Volumn 84, Issue 4, 2000, Pages 347-353

  Koizumi, Ryuichi ^a   Kanai, Hideo ^a   Maezawa, Akira ^a   Kanda, Tsugiyasu ^a   Nojima, Yoshihisa ^a   Naruse, Takuji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Crescentic glomerulonephritis; Protease inhibitor; Ulinastatin

Indexed keywords

COMPLEMENT; PROTEINASE INHIBITOR; ULINASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG RESPONSE; GLOMERULONEPHRITIS; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0034068882     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045610     Document Type: Article

References (41)

1. Wachter E, Hochstrasser K: Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-α-trypsin inhibitor. IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. Hoppe Seylers Z Physiol Them 1981;362: 1351-1355.
2. Sumi H, Takada Y, Takada A: Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb Res 1977;11:747-754.
3. Gebhard W, Hochstrasser K, Fritz H, Enghild JJ, Pizzo SV, Salvesen G: Structure of inter-α-inhibitor (inter-α-trypsin inhibitor) and pre-α-inhibitor: Current stale and proposition of a new terminology. Biol Chem Hoppe Seyler 1990;371(suppl): 13-22.
4. Gebhard W, Hochstrasser K: Inter-α-chain inhibitor and its close relatives: in Barret AJ, Salbesen G (eds): Protease Inhibitors. Amsterdam, Elsevier, 1986, pp 389-401.
5. Hiyama A, Takeda J, Kotake Y, Morisaki H, Fukushima K: A human urinary protease inhibitor (Ulinastatin) inhibits neutrophil extra-cellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vase Anesth 1997; 11:580-584.
6. Li XK, Matin AF, Suzuki H, Uno T, Yamaguchi T, Harada Y: Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation 1993;56:1331-1336.
7. Shibata T, Yamamoto F, Suehiro S, Kinoshita H: Effects of protease inhibitors on postischmic recovery of the heart. Cardiovasc Drugs Ther 1997;11:547-556.
8. Umeki S, Tsukiyama K, Okimoto N, Soejima R: Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity. Am J Med Sci 1989;298:221-226.
9. 2) poisoning. Nephron 1991;58:300-305.
10. Kobayashi H, Ohi H, Terao T: Prevention by urinastatin of cis-diamminedichloroplatinum-induced nephrotoxicity in rabbits: Comparison of urinary enzyme excretions and morphological alterations by electron microscopy. Asia Oceania J Obstet Gynaecol 1991;17:277-288.
11. Yamasaki F, Ishibashi M, Nakakuki M, Watanabe M, Shinkawa T, Mizota M: Protective action of Ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility. Nephron 1996;74:158-167.
12. Ishibashi M, Yamasaki F, Nakakuki M, Shinkawa T, Mizota M: Cytoprotective effect of Ulinastatinon LLC-PK1 cells treated with antimycin A, gentamicin, and cisplatin. Nephron 1997;76:300-306.
13. Schreiner GF, Cotran RS, Pardo V, Unanue ER: A mononuclear cell component in experimental immunological glomeruloncphritis. J Exp Med 1978;147:369-384.
14. Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D'Amico G: The detection of monocytes in human glomerulonephritis. Kidney Int 1985;28:513-519.
15. Oda T, Hotta O, Taguma Y, Kitamura H, Sudo K, Horigome I, Chiba S, Yoshizawa N, Nagura H: Involvement of neutrophil elastase in crescentic glomerulonephritis. Hum Pathol 1997; 28:720-728.
16. Heeringa P, van Goor H, Moshage H, Klok PA, Huitema MG, de Jager A, Schep AJ, Kallenberg CG: Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-my-eloperoxidase associated crescentic glomerulonephritis. Kidney Int 1998;53:382-393.
17. Falk RJ, Terrell RS, Charles LA, Jeunette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-4119.
18. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 1996;7:2271-2278.
19. Le Hir M, Haas C, Marino M, Ryffel B: Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 1998;78:1625-1631.
20. Krakower CA, Grecnspon SA: Localization of the nephrotoxic antigen within the isolated renal glomerulus. Arch Pathol Lab Med 1951;51: 629-639.
21. Kanai H, Hiromura K, Kuroiwa T, Maezawa A, Yano S, Naruse T: Roe of serotonin in nephrotoxic serum nephritis in WKY rats. J Lab Clin Med 1997;129:557-566.
22. Yamamoto S, Kubotsu K, Kida M, Kondo K, Matsuura S, Uchiyama S, Yonekawa O, Kanno T: Automated homogeneous liposome-based assay system for total complement activity. Clin Chem 1995;41:586-590.
23. Kihara K, Nagata N, Takasaki M: Protective effect of urinastatin on ischemic renal injury in rabbits (English abstract). Nippon Jinzo Gakkai Shi 1991;33:673-677.
24. Wilson CB: Renal response to immunologic glomerular injury; in Brenner BM (ed): The Kidney, ed 5. Philadelphia, Saunders, 1996, pp 1284-1288.
25. Sandhaus RA: Elastase may play a central role in neutrophil migration through connective tissue; in Taylor JC, Mittman C (eds): Pulmonary Emphysema and Proteolysis. New York Academic Press, 1986, pp 1-227.
26. Aosasa S, Ono S, Seki S, Takayama E, Tadakuma T, Hiraide H, Mochizuki H: Inhibitory effect of protease inhibitor on endothelial cell activation. J Surg Res 1998;80:182-187.
27. Mainardi CL, Dixit SN, Kang AH: Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem 1980;255:5435-5441.
28. Johnson RJ, Couser WG, Alpers CE, Vissers M, Schulze M, Klebanoff SJ: The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med 1988;168;1169-1174.
29. Davin JC, Davies M, Foidart JM, Foidart JB, Deehenne CA, Mahieu PR: Relation between urinary proteinases and proteinuria in rats with a glomerular disease. Adv Exp Med Biol 1988; 240:267-273.
30. Sanders E, Davies M, Coles GA: On the pathogenesis of glomerulonephritis: A clinico-pathological study indicating that neutrophils attack and degrade glomerular basement membrane. Ren Physiol 1980;3:355-359.
31. Feith GW, Assmann KJ, Bogman MJ, van Compel AP, Schalkwijk J, Koene RA: Lack of albuminuria in the early heterologous phase of anti-GBM nephritis in beige mice. Kidney Int 1993;43:824-827.
32. Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Yamada Y, Kasai T, Taki K, Yoshida M: The inhibitory actions of protease inhibitors on the production of polymorphonuclear leukocyte elastase and interleukin-8. Res Commun Chem Pathol Pharmacol 1993;82:27-34.
33. Nishijima J, Hiraoka N, Murata A, Oka Y, Kitagawa K, Tanaka N, Toda H, Mori T: Proease inhibitors (gebexate mesylate and Ulinastatin) stimulate intracellular chemiluminescence in human neutrophils. J Leukoc Biol 1992;52:262-268.
34. 2+ in human neutrophils and HUVEC cells. Biochem Biophys Res Commun 1995;207:324-330.
35. Aihara T, Shiraishi M, Hiroyasu S, Hatsuse K, Mochizuki H, Seki S, Hiraide H, Muto Y: Ulinastatin, a protease inhibitor, atttenuates hepatic ischemia/reperfusion injury by downregulating TNF-α in the liver. Transplant Proc 1998;30:3732-3734.
36. Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Therapeutic effect of combined treatment with monoclonal antibodies against intercellular adhesion molecule I and lymphocyte-function-associated antigen 1 in Masugi nephritis of WKY rats. Nephron 1995;71:101-102.
37. 1-microglobulin/inter-α-trypsin inhibitor light chain and its expression in acute inflammation. J Biochem (Tokyo) 1994;116:767-772.
38. Ohzawa T, Takahashi Y, Tsuchiya T, Ogihira T, Nagai Y, Kohda K, Tanaka S, Ishiguro J: Studies on the metabolic fate of Ulinastatin. 1. Pharmacokinetics in rats, mice, and rabbits following a single intravenous dose (English abstract). Xenobiotic Metab Deposit 1990;5: 739-753.
39. Baricos WH, O'Connor SE, Cortez SL, Wu LT, Shah SV: The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis. Biochem Biophys Res Commun 1988;155:1318-1323.
40. Baricos WH, Cortez SL, Le QC, Wu LT, Shaw E, Hanada K, Shah SV: Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis. Arch Bioehem Biophys 1991;288:468-472.
41. Suzuki S, Gejyo F, Kuroda T, Kazama JJ, Imai N, Kimura H, Arakawa M: Effects of a novel elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats. Kidney Int 1998;53: 1201-1208.